期刊文献+

2型糖尿病肾病患者血清金属蛋白酶9及其组织抑制因子1水平变化的临床意义 被引量:20

Clinical significance of serum metalloproteinase mat rix-9 and its tissue inhibitor-1 in type 2 diabetic patients with nephropathy
原文传递
导出
摘要 测定 2型糖尿病肾病 (DN)患者和正常对照者血清基质金属蛋白酶 9(MMP 9) ,MMP组织抑制物 1 (TIMP 1 ) ,Ⅳ型胶原水平 ,以尿白蛋白排泄率判断DN严重程度。结果显示血清TIMP 1和Ⅳ型胶原水平随DN严重程度而明显升高 ,MMP 9呈降低趋势。TIMP 1、MMP Serum metalloproteinase matrix (M MP )-9, tissue inhibitor of metalloproteinase (TIMP)-1 and type Ⅳ collagen level s were measured in patients with diabetic nephropathy (DN). The severity of DN w as determined by urinary albumin excretion rate. The results show that signific ant increases of serum TIMP-1 and type Ⅳ collagen depend on severity of DN, wh ile MMP-9 tends to decline. TIMP-1 and MMP-9 seem to participate in the patha genesis of DN.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2003年第1期52-53,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 基质金属蛋白酶 基质金属蛋白酶组织抑制物1 糖尿病肾病 Matrix metalloproteinases Tissue inhib itor of metalloproteinase-1 Diabetic nephropathies (Chin J Endocrinol Metab, 2003,19:52-53)
  • 相关文献

参考文献3

  • 1Suzuki D;Miyazaki M;Jinde K.In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type Ⅳ collagen in diabetic nephropathy[J],1997(1).
  • 2Kanauchi M;Nishioka H;Nakashiam Y.Role of tissue inhibitors of metalloproteinase in diabetic nephropathy,1996(03).
  • 3Ebihara I;Nakamura T;Shimada N.Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus,1998.

同被引文献163

引证文献20

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部